{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:37:08Z","timestamp":1792798628528,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2022R1C1C1006166"],"award-info":[{"award-number":["2022R1C1C1006166"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute of Health","award":["R01-AG065517"],"award-info":[{"award-number":["R01-AG065517"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-026-03720-7","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:46:45Z","timestamp":1772192805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["IL-18 binding protein attenuates neuroinflammation and cognitive decline in Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"23","author":[{"given":"Dae Ki","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hoon","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minwoo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sowon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Hee","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Su","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"3720_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ. The amyloid hypothesis of alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science. 2002;297:353\u20136.","journal-title":"Science"},{"key":"3720_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth HW, LaFerla FM. Alzheimer\u2019s disease. N Engl J Med. 2010;362:329\u201344.","journal-title":"N Engl J Med"},{"key":"3720_CR3","doi-asserted-by":"publisher","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","volume":"1","author":"CL Masters","year":"2015","unstructured":"Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL. Alzheimer\u2019s disease. Nat Rev Dis Primers. 2015;1:15056.","journal-title":"Nat Rev Dis Primers"},{"key":"3720_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell. 2019;179:312\u201339.","journal-title":"Cell"},{"key":"3720_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P. Neuroinflammation and microglial activation in alzheimer disease: where do we go from here? Nat Rev Neurol. 2021;17:157\u201372.","journal-title":"Nat Rev Neurol"},{"key":"3720_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00401-024-02790-2","volume":"148","author":"P Botella Lucena","year":"2024","unstructured":"Botella Lucena P, Heneka MT. Inflammatory aspects of alzheimer\u2019s disease. Acta Neuropathol. 2024;148:31.","journal-title":"Acta Neuropathol"},{"key":"3720_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/378088a0","volume":"378","author":"H Okamura","year":"1995","unstructured":"Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature. 1995;378:88\u201391.","journal-title":"Nature"},{"key":"3720_CR8","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.tins.2005.06.008","volume":"28","author":"U Felderhoff-Mueser","year":"2005","unstructured":"Felderhoff-Mueser U, Schmidt OI, Oberholzer A, Buhrer C, Stahel PF. IL-18: a key player in neuroinflammation and neurodegeneration? Trends Neurosci. 2005;28:487\u201393.","journal-title":"Trends Neurosci"},{"key":"3720_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1742-2094-7-9","volume":"7","author":"S Alboni","year":"2010","unstructured":"Alboni S, Cervia D, Sugama S, Conti B. Interleukin 18 in the CNS. J Neuroinflammation. 2010;7:9.","journal-title":"J Neuroinflammation"},{"key":"3720_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.brainres.2008.11.083","volume":"1253","author":"JT Yu","year":"2009","unstructured":"Yu JT, Tan L, Song JH, Sun YP, Chen W, Miao D, Tian Y. Interleukin-18 promoter polymorphisms and risk of late onset alzheimer\u2019s disease. Brain Res. 2009;1253:169\u201375.","journal-title":"Brain Res"},{"key":"3720_CR11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.brainres.2011.01.025","volume":"1381","author":"X Xu","year":"2011","unstructured":"Xu X, Li D, He Q, Gao J, Chen B, Xie A. Interleukin-18 promoter polymorphisms and risk of parkinson\u2019s disease in a Han Chinese population. Brain Res. 2011;1381:90\u20134.","journal-title":"Brain Res"},{"key":"3720_CR12","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1007\/s11033-013-3013-5","volume":"41","author":"S Karakas Celik","year":"2014","unstructured":"Karakas Celik S, Oz ZS, Dursun A, Unal A, Emre U, Cicek S, Keni FM. Interleukin 18 gene polymorphism is a risk factor for multiple sclerosis. Mol Biol Rep. 2014;41:1653\u20138.","journal-title":"Mol Biol Rep"},{"key":"3720_CR13","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1136\/jnnp.2006.103242","volume":"78","author":"P Bossu","year":"2007","unstructured":"Bossu P, Ciaramella A, Moro ML, Bellincampi L, Bernardini S, Federici G, Trequattrini A, Macciardi F, Spoletini I, Di Iulio F, et al. Interleukin 18 gene polymorphisms predict risk and outcome of alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 2007;78:807\u201311.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3720_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/1742-2094-9-199","volume":"9","author":"EM Sutinen","year":"2012","unstructured":"Sutinen EM, Pirttila T, Anderson G, Salminen A, Ojala JO. Pro-inflammatory interleukin-18 increases alzheimer\u2019s disease-associated amyloid-beta production in human neuron-like cells. J Neuroinflammation. 2012;9:199.","journal-title":"J Neuroinflammation"},{"key":"3720_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0306-4522(01)00405-5","volume":"108","author":"B Curran","year":"2001","unstructured":"Curran B, O\u2019Connor JJ. The pro-inflammatory cytokine interleukin-18 impairs long-term potentiation and NMDA receptor-mediated transmission in the rat hippocampus in vitro. Neuroscience. 2001;108:83\u201390.","journal-title":"Neuroscience"},{"key":"3720_CR16","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.neurobiolaging.2007.06.006","volume":"30","author":"J Ojala","year":"2009","unstructured":"Ojala J, Alafuzoff I, Herukka SK, van Groen T, Tanila H, Pirttila T. Expression of interleukin-18 is increased in the brains of alzheimer\u2019s disease patients. Neurobiol Aging. 2009;30:198\u2013209.","journal-title":"Neurobiol Aging"},{"issue":"Suppl 1","key":"3720_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/jnc.13217","volume":"136","author":"LC Freeman","year":"2016","unstructured":"Freeman LC, Ting JP. The pathogenic role of the inflammasome in neurodegenerative diseases. J Neurochem. 2016;136(Suppl 1):29\u201338.","journal-title":"J Neurochem"},{"key":"3720_CR18","doi-asserted-by":"crossref","unstructured":"Piancone F, La Rosa F, Marventano I, Saresella M, Clerici M. The role of the inflammasome in neurodegenerative diseases. Molecules. 2021;26:953.","DOI":"10.3390\/molecules26040953"},{"key":"3720_CR19","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, Griep A, Axt D, Remus A, Tzeng TC, et al. NLRP3 is activated in alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature. 2013;493:674\u20138.","journal-title":"Nature"},{"key":"3720_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature25158","volume":"552","author":"C Venegas","year":"2017","unstructured":"Venegas C, Kumar S, Franklin BS, Dierkes T, Brinkschulte R, Tejera D, Vieira-Saecker A, Schwartz S, Santarelli F, Kummer MP, et al. Microglia-derived ASC specks cross-seed amyloid-beta in alzheimer\u2019s disease. Nature. 2017;552:355\u201361.","journal-title":"Nature"},{"key":"3720_CR21","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-018-01957-y","volume":"137","author":"IC Stancu","year":"2019","unstructured":"Stancu IC, Cremers N, Vanrusselt H, Couturier J, Vanoosthuyse A, Kessels S, Lodder C, Brone B, Huaux F, Octave JN, et al. Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo. Acta Neuropathol. 2019;137:599\u2013617.","journal-title":"Acta Neuropathol"},{"key":"3720_CR22","doi-asserted-by":"publisher","first-page":"E12427","DOI":"10.1073\/pnas.1815915115","volume":"115","author":"H Wang","year":"2018","unstructured":"Wang H, Liu X, Chen S, Ye K. Spatiotemporal activation of the C\/EBPbeta\/delta-secretase axis regulates the pathogenesis of alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2018;115:E12427\u201334.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3720_CR23","doi-asserted-by":"publisher","first-page":"102212","DOI":"10.1016\/j.pneurobio.2021.102212","volume":"209","author":"ZH Wang","year":"2022","unstructured":"Wang ZH, Xia Y, Wu Z, Kang SS, Zhang JC, Liu P, Liu X, Song W, Huin V, Dhaenens CM, et al. Neuronal ApoE4 stimulates C\/EBPbeta activation, promoting alzheimer\u2019s disease pathology in a mouse model. Prog Neurobiol. 2022;209:102212.","journal-title":"Prog Neurobiol"},{"key":"3720_CR24","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1093\/brain\/awab062","volume":"144","author":"Y Yao","year":"2021","unstructured":"Yao Y, Kang SS, Xia Y, Wang ZH, Liu X, Muller T, Sun YE, Ye K. A delta-secretase-truncated APP fragment activates CEBPB, mediating alzheimer\u2019s disease pathologies. Brain. 2021;144:1833\u201352.","journal-title":"Brain"},{"key":"3720_CR25","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s00011-021-01509-3","volume":"70","author":"J Ma","year":"2021","unstructured":"Ma J, Yang X, Chen X. C\/EBPbeta is a key transcription factor of ox-LDL inducing THP-1 cells to release multiple pro-inflammatory cytokines. Inflamm Res. 2021;70:1191\u20139.","journal-title":"Inflamm Res"},{"key":"3720_CR26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S1074-7613(00)80013-8","volume":"10","author":"D Novick","year":"1999","unstructured":"Novick D, Kim SH, Fantuzzi G, Reznikov LL, Dinarello CA, Rubinstein M. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity. 1999;10:127\u201336.","journal-title":"Immunity"},{"key":"3720_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10238-009-0036-2","volume":"9","author":"XT Shao","year":"2009","unstructured":"Shao XT, Feng L, Gu LJ, Wu LJ, Feng TT, Yang YM, Wu NP, Yao HP. Expression of interleukin-18, IL-18BP, and IL-18R in serum, synovial fluid, and synovial tissue in patients with rheumatoid arthritis. Clin Exp Med. 2009;9:215\u201321.","journal-title":"Clin Exp Med"},{"key":"3720_CR28","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.4049\/jimmunol.168.7.3608","volume":"168","author":"A Corbaz","year":"2002","unstructured":"Corbaz A, ten Hove T, Herren S, Graber P, Schwartsburd B, Belzer I, Harrison J, Plitz T, Kosco-Vilbois MH, Kim SH, et al. IL-18-binding protein expression by endothelial cells and macrophages is up-regulated during active crohn\u2019s disease. J Immunol. 2002;168:3608\u201316.","journal-title":"J Immunol"},{"key":"3720_CR29","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1084\/jem.20190669","volume":"216","author":"S Belkaya","year":"2019","unstructured":"Belkaya S, Michailidis E, Korol CB, Kabbani M, Cobat A, Bastard P, Lee YS, Hernandez N, Drutman S, de Jong YP, et al. Inherited IL-18BP deficiency in human fulminant viral hepatitis. J Exp Med. 2019;216:1777\u201390.","journal-title":"J Exp Med"},{"key":"3720_CR30","doi-asserted-by":"publisher","first-page":"5913","DOI":"10.4049\/jimmunol.167.10.5913","volume":"167","author":"R Faggioni","year":"2001","unstructured":"Faggioni R, Cattley RC, Guo J, Flores S, Brown H, Qi M, Yin S, Hill D, Scully S, Chen C, et al. IL-18-binding protein protects against lipopolysaccharide- induced lethality and prevents the development of Fas\/Fas ligand-mediated models of liver disease in mice. J Immunol. 2001;167:5913\u201320.","journal-title":"J Immunol"},{"key":"3720_CR31","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.4049\/jimmunol.171.3.1164","volume":"171","author":"T Plitz","year":"2003","unstructured":"Plitz T, Saint-Mezard P, Satho M, Herren S, Waltzinger C, de Carvalho Bittencourt M, Kosco-Vilbois MH, Chvatchko Y. IL-18 binding protein protects against contact hypersensitivity. J Immunol. 2003;171:1164\u201371.","journal-title":"J Immunol"},{"key":"3720_CR32","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/j.thromres.2011.07.012","volume":"128","author":"NN Shan","year":"2011","unstructured":"Shan NN, Ji XB, Wang X, Li Y, Liu X, Zhu XJ, Hou M. In vitro recovery of Th1\/Th2 balance in PBMCs from patients with immune thrombocytopenia through the actions of IL-18BPa\/Fc. Thromb Res. 2011;128:e119\u2013124.","journal-title":"Thromb Res"},{"key":"3720_CR33","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12967-021-03071-2","volume":"19","author":"HK Min","year":"2021","unstructured":"Min HK, Kim S, Lee JY, Kim KW, Lee SH, Kim HR. IL-18 binding protein suppresses IL-17-induced osteoclastogenesis and rectifies type 17 helper T cell \/ regulatory T cell imbalance in rheumatoid arthritis. J Transl Med. 2021;19:392.","journal-title":"J Transl Med"},{"key":"3720_CR34","first-page":"1891","volume":"23","author":"XL Lin","year":"2019","unstructured":"Lin XL, Zhu J, Wang LM, Yan F, Sha WP, Yang HL. MiR-92b-5p inhibitor suppresses IL-18 mediated inflammatory amplification after spinal cord injury via IL-18BP up-regulation. Eur Rev Med Pharmacol Sci. 2019;23:1891\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3720_CR35","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1097\/00004647-200208000-00008","volume":"22","author":"I Yatsiv","year":"2002","unstructured":"Yatsiv I, Morganti-Kossmann MC, Perez D, Dinarello CA, Novick D, Rubinstein M, Otto VI, Rancan M, Kossmann T, Redaelli CA, et al. Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury. J Cereb Blood Flow Metab. 2002;22:971\u20138.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3720_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov D, Hall DR, Xia B, Porter KA, Padhorny D, Yueh C, Beglov D, Vajda S. The cluspro web server for protein-protein Docking. Nat Protoc. 2017;12:255\u201378.","journal-title":"Nat Protoc"},{"key":"3720_CR37","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, Tunyasuvunakool K, Bates R, Zidek A, Potapenko A, et al. Highly accurate protein structure prediction with alphafold. Nature. 2021;596:583\u20139.","journal-title":"Nature"},{"key":"3720_CR38","doi-asserted-by":"publisher","first-page":"eabj8658","DOI":"10.1126\/sciadv.abj8658","volume":"8","author":"Y Xia","year":"2022","unstructured":"Xia Y, Qadota H, Wang ZH, Liu P, Liu X, Ye KX, Matheny CJ, Berglund K, Yu SP, Drake D, et al. Neuronal C\/EBPbeta\/AEP pathway shortens life span via selective gabanergic neuronal degeneration by FOXO repression. Sci Adv. 2022;8:eabj8658.","journal-title":"Sci Adv"},{"key":"3720_CR39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-4939-8994-2_10","volume":"1916","author":"AK Kraeuter","year":"2019","unstructured":"Kraeuter AK, Guest PC, Sarnyai Z. The Y-Maze for assessment of Spatial working and reference memory in mice. Methods Mol Biol. 2019;1916:105\u201311.","journal-title":"Methods Mol Biol"},{"key":"3720_CR40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3233\/JAD-230150","volume":"94","author":"A Gonzalez","year":"2023","unstructured":"Gonzalez A, Calfio C, Luttges V, Gonzalez-Madrid A, Guzman C. The multifactorial etiopathogenesis of alzheimer\u2019s disease: neuroinflammation as the major contributor. J Alzheimers Dis. 2023;94:95\u2013100.","journal-title":"J Alzheimers Dis"},{"key":"3720_CR41","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.neurobiolaging.2012.10.007","volume":"34","author":"D Caruso","year":"2013","unstructured":"Caruso D, Barron AM, Brown MA, Abbiati F, Carrero P, Pike CJ, Garcia-Segura LM, Melcangi RC. Age-related changes in neuroactive steroid levels in 3xTg-AD mice. Neurobiol Aging. 2013;34:1080\u20139.","journal-title":"Neurobiol Aging"},{"key":"3720_CR42","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in Transgenic mice with five Familial alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26:10129\u201340.","journal-title":"J Neurosci"},{"key":"3720_CR43","doi-asserted-by":"publisher","first-page":"115938","DOI":"10.1016\/j.biopha.2023.115938","volume":"169","author":"Q Ren","year":"2023","unstructured":"Ren Q, Liu Z, Wu L, Yin G, Xie X, Kong W, Zhou J, Liu S. C\/EBPbeta: the structure, regulation, and its roles in inflammation-related diseases. Biomed Pharmacother. 2023;169:115938.","journal-title":"Biomed Pharmacother"},{"key":"3720_CR44","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41380-020-0687-7","volume":"26","author":"Z Wu","year":"2021","unstructured":"Wu Z, Xia Y, Wang Z, Su Kang S, Lei K, Liu X, Jin L, Wang X, Cheng L, Ye K. C\/EBPbeta\/delta-secretase signaling mediates parkinson\u2019s disease pathogenesis via regulating transcription and proteolytic cleavage of alpha-synuclein and MAOB. Mol Psychiatry. 2021;26:568\u201385.","journal-title":"Mol Psychiatry"},{"key":"3720_CR45","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1006\/bbrc.1999.2064","volume":"267","author":"H Muhl","year":"2000","unstructured":"Muhl H, Kampfer H, Bosmann M, Frank S, Radeke H, Pfeilschifter J. Interferon-gamma mediates gene expression of IL-18 binding protein in nonleukocytic cells. Biochem Biophys Res Commun. 2000;267:960\u20133.","journal-title":"Biochem Biophys Res Commun"},{"key":"3720_CR46","doi-asserted-by":"publisher","first-page":"16957","DOI":"10.1073\/pnas.262663399","volume":"99","author":"V Hurgin","year":"2002","unstructured":"Hurgin V, Novick D, Rubinstein M. The promoter of IL-18 binding protein: activation by an IFN-gamma -induced complex of IFN regulatory factor 1 and CCAAT\/enhancer binding protein beta. Proc Natl Acad Sci U S A. 2002;99:16957\u201362.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3720_CR47","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jneuroim.2008.09.012","volume":"205","author":"JO Ojala","year":"2008","unstructured":"Ojala JO, Sutinen EM, Salminen A, Pirttila T. Interleukin-18 increases expression of kinases involved in Tau phosphorylation in SH-SY5Y neuroblastoma cells. J Neuroimmunol. 2008;205:86\u201393.","journal-title":"J Neuroimmunol"},{"key":"3720_CR48","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3389\/fncel.2014.00214","volume":"8","author":"EM Sutinen","year":"2014","unstructured":"Sutinen EM, Korolainen MA, Hayrinen J, Alafuzoff I, Petratos S, Salminen A, Soininen H, Pirttila T, Ojala JO. Interleukin-18 alters protein expressions of neurodegenerative diseases-linked proteins in human SH-SY5Y neuron-like cells. Front Cell Neurosci. 2014;8:214.","journal-title":"Front Cell Neurosci"},{"key":"3720_CR49","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1182\/blood-2017-06-789552","volume":"131","author":"C Girard-Guyonvarc\u2019h","year":"2018","unstructured":"Girard-Guyonvarc\u2019h C, Palomo J, Martin P, Rodriguez E, Troccaz S, Palmer G, Gabay C. Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice. Blood. 2018;131:1430\u201341.","journal-title":"Blood"},{"key":"3720_CR50","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1182\/blood-2017-12-820852","volume":"131","author":"ES Weiss","year":"2018","unstructured":"Weiss ES, Girard-Guyonvarc\u2019h C, Holzinger D, de Jesus AA, Tariq Z, Picarsic J, Schiffrin EJ, Foell D, Grom AA, Ammann S, et al. Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome. Blood. 2018;131:1442\u201355.","journal-title":"Blood"},{"key":"3720_CR51","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12979-023-00397-x","volume":"20","author":"M Cao","year":"2023","unstructured":"Cao M, Liu J, Zhang X, Wang Y, Hou Y, Song Q, Cui Y, Zhao Y, Wang P. IL-17A promotes the progression of alzheimer\u2019s disease in APP\/PS1 mice. Immun Ageing. 2023;20:74.","journal-title":"Immun Ageing"},{"key":"3720_CR52","doi-asserted-by":"publisher","first-page":"109574","DOI":"10.1016\/j.celrep.2021.109574","volume":"36","author":"HC Brigas","year":"2021","unstructured":"Brigas HC, Ribeiro M, Coelho JE, Gomes R, Gomez-Murcia V, Carvalho K, Faivre E, Costa-Pereira S, Darrigues J, de Almeida AA, et al. IL-17 triggers the onset of cognitive and synaptic deficits in early stages of alzheimer\u2019s disease. Cell Rep. 2021;36:109574.","journal-title":"Cell Rep"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03720-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03720-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03720-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T14:04:34Z","timestamp":1775225074000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03720-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3720"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03720-7","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol and all procedures were approved by Emory Institutional Animal Care and Use Committee. Animal care and handling were performed according to NIH animal care guidelines, the 1975 Declaration of Helsinki, and Emory University School of Medicine guidelines. Using human samples was approved by Emory Integrated Core Facilities.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}